Stimulation of the T cell antigen receptor (TCK) activates a protein tyrosine kinase and leads to the tyrosine phosphorylation of phosphoinositide-specific phospholipase C-'yl (PLC3,1). The molecular interactions involved in this phosphorylation are not known. After stimulation of the TCK on Jurkat T cells, tyrosine-phosphorylated proteins of 36, 38, 58, and 63 kD coprecipitate with PLC3,1. An identical pattern of proteins precipitate with TrpE fusion proteins that contain the Src homology (SH) 2 domains of PLC'y1, indicating that these regions of PLC'y1 are responsible for binding. TCR stimulation leads to an association between the SH2 domains of PLC3,1 and a protein tyrosine kinase, which, by peptide mapping, is identical to p56 ~k. These studies establish that p56 k~ associates with PLC3,1 as a result of TCK stimulation of Jurkat ceils, suggesting that p56 ~t plays a central role in coupling the TCR to the activation of PLC'y1.
the receptors for epidermal growth factor (EGF) and platdetderived growth factor (PDGF), is the direct binding of PLCT1 to the receptor (13) (14) (15) (16) (17) . This binding requires autophosphorylation of the receptor and appears to be mediated by the Src homology 2 (SH2) domains of PLC3,1 (18) (19) (20) . SH2 domains are conserved sequences of '~100 amino acids that are found in a number of signaling molecules (20) . By recognizing specific peptide sequences that contain phosphotyrosine, SH2 domains likely play a key role in directing protein-protein interactions during signal transduction (20) . Herein, we have examined the possibilities that PLC'y1 associates with tyrosine phosphorylated molecules as a result of TCR stimulation of Jurkat cells, and that this association involves the SH2 domains of PLC'yl.
Materials and Methods
Reagents. TrpE fusion proteins containing the SH2 domains of PLC3q and ras GTPase activating protein (GAP) were isolated from Escherichia coli RR1 possessing the appropriate pATH expression plasmid as described (18, 19) . Rabbit antisera to pSC k and to PLC3~I were supplied by Drs. J. Bolen (Bristol-Meyers Squibb, Princeton, NJ) and R. Schatzman (Syntex Corp., Palo Alto, CA), respectively. Jurkat cells and the mAb C305 (reactive with the Jurkat TCK) were gifts of Dr. A. Weiss (University of California, San Francisco, CA).
Imratmoprecipitation, Precipitations Using TrpE Fusion Proteins, and
Imraunoblotting. Cells were lysed in an ice-cold buffer containing 1% Triton X-100 as described (18) . After a 30-min incubation on ice, the lysates were subjected to a 15-rain centrifugation at 14,000 g. To immunoprecipitate PLC3,1 or p56 k~, the clarified lysate was incubated with the appropriate rabbit antiserum complexed to Pansorbin (Calbiochem Corp., La Jolla, CA). For precipitations with the TrpE fusion proteins, lysates were incubated with the indicated TrpE fusion protein immob'flized by a T_rpE mAb (Oncogene Science, Inc., Manhasset, NY) complexed to Pansorbin with a rabbit antiserum to mouse Ig (Cappel Laboratories, Durham, NC). After incubation with the Jurkat lysate for 90 min at 4~ the precipitation complexes were recovered by centfifugation, washed three times, and then duted in Laemmli sample buffer. Samples were subjected to electrophoresis under reducing conditions in 5-15% polyacrylamide gradient gels, transferred to polyvinylidene difluoride (PVDF) membranes (Millipore Corp., Bedford, MA), and analyzed by immunoblotting with a mouse IgG2b mAb (4G10) to phosphotyrosine (Upstate Biologicals, Inc., Lake Placid, NY), revealed by an alkaline phosphatase-conjugated mAb specific for mouse IgG2b (PharMingen, San Diego, CA).
In Vitro Kinase Assays. Precipitation complexes were washed in a kinase wash buffer (1% Triton X-100; 150 mM NaC1; 50 mM Hepes, pH 7.5; 1 mM Na3VO~), incubated for 15 rain on ice with 27 #Ci/sample 3r (Amersham International, Amersham, Bucks, UK, 6,000 Ci/mmole) in a kinase reaction buffer (100 mM NaC1; 20 mM Hepes, pH 7.4; 5 mM MnCh; 5 mM MgC12) (final vol, 25 #1), and then washed twice in the above wash buffer containing 1 mM EDTA. The reaction products were solubilized in Laemmli sample buffer and resolved by electrophoresis under reducing conditions in 5-15% polyacrylamide gels. After fixation for 1 h in 10% ghcial acetic acid/10% isopropanol, the gds were treated with 1 M KOH for 2 h at 55~ followed by incubation in 10% glacial acetic acid/10% isopropanol.
Peptide Mapping and Phosphoamino Acid Analysis. In vitro kinase reactions using precipitations from lysates of TCR-stimulated Jurkat cells were analyzed as described above except that the gels were not treated with KOH. For peptide mapping, the bands of interest were identified by autoradiography, precisely excised from the dried gel, rehydrated, and digested with staphylococcal V8 protease (Calbiochem Corp.) as described by Cleveland et al. (21) . For phosphoamino acid analysis, the 32p-labeled proteins were transferred to PVDF membranes, duted, and then hydrolyzed in 6N HCI for 1 h at 110~ as described (22) . Phosphoamino acids were resolved on thin-la~ cellulose plates by two-dimensinnal electrophoresis using a Hunter thin-layer electrophoresis system (HTLE-7000; CBS Scientific, Dd Mar, CA) (22) .
Results
The addition of a TCK mAb to Jurkat cells induces the tyrosine phosphorylation of PLC3,1 (8) (9) (10) (11) (12) . When PLC3'I is immunopredpitated from lysates of TCRostimulatedJurkat cells, we observe that four prominent tyrosine-phosphorylated proteins of 36, 38, 58, and 63 kD (pp36, pp38, pp58, and pp63) consistently coprecipitate with PLC3,1 (Fig. 1) . To determine whether the coprecipitation of these rnolecules is a result of their binding to the SH2 domains of PLC'y1, we used fusion proteins of TrpE and PI.C'y1 SH2 domains as affinity ligands. Fusion proteins that have both the NH2-and COOH-terminal PLC3,1 SH2 domains precipitate tyrosine-phosphorylated proteins that exactly comigrate with Figure 1 . Tyrosine-phosphoryhted proteins from TCR-stimulatedJurkat cells coprecipitate with PLCT1 and bind to TrpE fusion proteins containing the NH2 SH2 domain of PLC~I. Jurkat cells (8 x 10~ cells/sample) were stimulated for 2 rain at 37~ with the TCR mAb C305 and then lysed with an ice-cold buffer containing 1% Triton X-100 and phosphatase inhibitors as described (13) . Endogenous PLCT1 was immunoprecipitated using a specific antiserum as described in Materials and Methods. Alternatively, lysates were subjected to precipitations using TrpE fusion proteins that contained both the NHz-and COOH-terminal SH2 domains of
PLC'y1 (PLC, T-SH2), the NH2-terminal SH2 domain alone (PLCT1-SH2[N]), the COOH-terminal domain alone (PI..C~/I-SH2[C]), or the NH2-and COOH-terminal SH2 domains of p21 r~' GAP (GAP-SH2).
After resolution under reducing conditions on SDS-PAGE and transfer to PVDF membranes, tyrosine-phosphorylated proteins were detected by immunoblotting. The 150-kD tyrosine-phosphoryhted band in the PLC3'I immunoprecipitate comigrates with PLC3'I as detected by immunoblotting with anti-PLCqel (data not shown). (Arrows) Tyrosine-phosphoryhted proteins of 36, 38, 58, and 63 kD that coprecipitate with endogenous PLC3'I and with TrpE fusion proteins containing the NH2-terminal SH2 domain of PI.C'I,1.
PLC'yl-associated molecules. Comparable levels of all four tyrosine-phosphorylated proteins also bind to a fusion prorein that has only the NH2-terminal SH2 domain. In contrast, a fusion protein containing the COOH-terminal PLCT1 SH2 domain precipitates only barely detectable levels ofpp58 and pp63 molecules and does not precipitate pp36 and pp38 (Fig. 1) . The NH2-terminal SH2 domain, therefore, appears to be primarily responsible for the binding of these tyrosinephosphorylated molecules to PLC'y1. The binding is specific for PLCT1 SH2 domains in that little or no binding is observed with a TrpE fusion protein that contains the SH2 domains of p21 '~ GAP (Fig. 1) or with TrpE alone (Fig. 2) . The TrpE/p21 ~' GAP fusion protein effectively precipitates tyrosine-phosphorylated PDGF and EGF receptors (18, 19) .
Only low level binding of the tyrosine-phosphorylated proteins to the TrpE/PLC'y1 SI-I2 fusion protein is detected in lysates from unstimulated Jurkat cells (Fig. 2) . Similarly, these molecules are either absent or only barely detectable when the endogenous PLCT1 is immunoprecipitated from unstimu- lated cells (data not shown). Within 30 s of T C K stimulation a substantial increase in the binding of all four molecules occurs (Hg. 2). Binding is maximal by 45 s and declines after 2 rain (Fig. 2) . In most, but not all experiments (compare Figs. 1 and 2), we observed induced bands of 72 and 105 kD at the earliest time points, a well as a 55-kD band whose binding was unaffected by receptor stimulation.
To determine whether a FTK associates with PLCy1, we performed in vitro kinase reactions using precipitates with the TrpE/PLC'y1 SH2 fusion protein and immunoprecipitates of the endogenous PLC'y1 (Fig. 3, A and B) . There is little or no kinase activity in precipitates from unstimulated cells or in precipitates using TrpE alone. After T C R stimulation, a protein kinase precipitates with the TrpE/PLCyl SH2 domain fusion protein and with the endogenous PLC'y1. In both cases, the in vitro kinase reaction yields a prominent doublet of phosphoproteins of 58 and 63 kD. Phosphoamino acid analysis of each of these phosphoproteins demonstrated that the phosphorylation occurred in tyrosine residues (Fig.  3 , C, and data not shown).
The 58 kD and 63 kD tyrosine-phosphorylated proteins that associate with PLC'y1 have apparent Mr similar to p59f~ and to p56 ~, a Src-like FFK which is noncovalently associated with the CD4 and CD8 coreceptors and which, because of differential serine phosphorylation, has two elec- (B) Jurkat cells were either lysed directly (-) or after stimulation (+) with the TCR mAb C305. Precipitatiom were performed using TrpE alone, the TrpE fusion protein containing the NH2-and COOH-terminal SH2 domains of PLC'y1, or a rabbit antiserum to p56 ~k. Kinase reactions were performed, and the reaction products analyzed as described in Materials and Methods. The autoradiograph was exposed for 3 h. The reaction products of the p56~i immunoprecipitares are from 106 Jurkat cells, whereas the other lanes represent precipitations from 10 x 106 cells. (C) Phosphoamino acid analysis of the 62-kD phosphoprotein generated from an in vitro kinase assay using the TrpE/PLC'y1-SH2 fusion protein. The positions of the phosphoamino acid standards are shown. trophoretic mobilities in activated T cells (23, 24) . On phosphotyrosine immunoblots, the two PLC3rl-associated molecules comigrate with p56 kk immunoprecipitated from TCR-stimulated Jurkat cells (data not shown). Furthermore, p56 ~k, which autophosphorylates during in vitro kinase reactions (23) (24) (25) (26) , comigrated with the 58-and 63-kD phosphoproteins observed with in vitro kinase reactions from either immunoprecipitated PLC',/1 or the fusion protein precipitates (Fig. 3 B) . To confirm that the PLC'~l-associated molecules are p56 kk, we compared the peptide maps of the phosphoproteins. As shown in Fig. 4 , the maps of the phosphoproteins generated from precipitates of the TrpE/PLC'y1 SH2 fusion protein are identical to those from p56 ~k.
Because TCR ligation induced an association between PLC3~I and tyrosine-phosphorylated p56 ~, we determined whether TCR stimulation altered the tyrosine phosphorylation of the latter. Consistent with previous reports that some p56 ~k is tyrosine-phosphorylated in unstimulated T cell lines (25, 26) , we observed that p56 ~k immunoprecipitated from unstimulatedJurkat cells contained phosphotyrosine (Fig. 5 ). There was a clear increase in the tyrosine phosphorylation of p56 ~k within 60 s of TCR stimulation (Fig. 5, second  lane) . In contrast to the immunoprecipitates from resting cells, several tyrosine-phosphorylated molecules coprecipitated with p56 ~k from TCR-stimulated cells. The apparent Mr of these molecules are identical to those of the 36-, 38-, and 72-kD molecules that associate with PLC3q (Fig. 5, second lane) .
We then precleared lysates with the TrpE/PLC3~I SH2 domain fusion protein to deplete the lysates of the molecules that bind PLC3q. This preclearing removed the molecules that coprecipitate with p56 ~k, confirming that these were identical to the PLC3,1-associated molecules (Fig. 5, fourth  lane) . Moreover, preclearing the lysates from TCR-stimulated cells reduced the amount of tyrosine-phosphorylated p56 ~k to the levels of unstimulated cells (Fig. 5 , compare the second and fourth lanes). Consistent with the absence of PTK activity in precipitations from unstimulated cells (Fig. 3) , the fusion protein did not remove any tyrosine-phosphorylated p56 ~k from the lysates of unstimulated cells (Fig. 5 , compare the first and third lanes).
Discussion
We observe that stimulation of the TCR on Jurkat cells leads to the binding of several tyrosine-phosphorylated molecules, including p56 t'k, to PLC'y1. Studies using TrpE/PLC3/1 fusion proteins indicate that these associates are mediated by the SH2 domains of PLC'y1, the same region of PLC'yl that binds to the tyrosine~phosphorylated EGF and PDGF receptors. The association with p56 ~ occurs within 30 s of TCR stimulation and thus coincides with the onset of tyrosine phosphorylation of PLC'y1 in Jurkat cells (8) (9) (10) (11) . The interaction between PLC'y1 and p56 ~k is transient and peaks several minutes before the reported association of PLC3,1 with CD3 (12) . The time course of the association between were either lysed directly (-) or stimulated with a TCK mAb for 60 s before lysis (+). p56 k/' was immunopredpitated with a specific antiserum, resolved by dec= trophoresis under reducing conditions on SDS-PAGE, transferred to PVDF, and then analyzed by immunoblotting with a mAb to phosphotyrosine. In the third and fourth hnes, the lysates were predeared with the TrpE/PI.C3,1 SH2 domain fusion protein before the immunoprecipitation of p56 k~. p56 uk and PLC'F1, therefore, is consistent with the possibility that p56 uk plays a role in TCR-mediated activation of PLC~/1. p56 ~ may be partly or solely responsible for tyrosine phosphorylation of PLC3/1. Alternatively, p56 ~ may phosphorylate molecules that associate with PLC3,1, and that are involved in its activation.
Our results lend additional support to earlier indications that p56 u~ may participate in TCK-mediated signaling. Recently Abraham et al. (27) observed augmented responses to antigen after expression of an activated form of p56 ~ in an antigen-specific T cell hybridoma. This augmentation occurred in the absence of cell-surface expression of CD4 and CD8 and, therefore, was independent of coreceptor ligation (27) . In T cells that express CD4 or CDS, "~30-60% of p56 u~ is complexed to these coreceptors (23) (24) (25) (26) . Interactions with p56 ~ appear to be at least partly responsible for the ability of CD4 to confer enhanced antigen responses upon T cell dones and hybridomas (28) . CD4 may be physically associated with the TCK, and there is evidence that maintaining CD4 and TCK in physical proximity enhances TCR-mediated fignaling (29, 30) . For example, in mAb-induced signaling, codustering of the TCK and CD4 (by means of heteroconjugates of mAb) substantially augments TCR-mediated PI turnover, whereas crosslinking CD4 and the TCK independently diminishes this response (31) .
In contrast to the findings presented here with p56 uk, we could not detect p59f~ in our PLC3,1 precipitates (data not shown), p59fr" coprecipitates with the TCR, and there are compelling data that p59~ has a role in TCK-mediated signaling (3, 4) . For example, T cells from transgenic mice that overexpress p59f~ have enhanced TCK-mediated Ca 2 § mobilization, suggesting that p59fr" regulates the coupling of the TCR to PI turnover (4). Our inability to detect an association between p59~ and PLC3,1 does not argue against a role for this, or any other PTK in TCR-mediated phosphorylation of PLC3,1. Activation of an "upstream" FTK, such as p59fr", might induce PLC3,1 phosphorylation indirectly by triggering the interaction between p56 ~k and PLC3~I. Alternatively, an association between PLC~/1 and p59fr" (or other PTKs) might not be stable under the conditions used here for precipitation. We also cannot be certain that p56 ~ is the only FFK present in our PLC3,1 precipitates, particularly in view of the precipitation of tyrosinephosphorylated molecules (pp36, pp38, pp72, ppl05) whose identity is uncertain.
The p56 kk that associates with PLC3,1 represents <5% of the p56 kk that can be immunopredpitated directly with a specific antiserum (note that, in Fig. 3 , one-tenth the cell number was used for the p56 ~k immunoprecipitates). The precise mechanism by which the TCK induces an association between PLC3,1 and this subset of p56 ~ remains to be determined. We find that TCR stimulation triggers an increase in the tyrosine phosphorylation of p56 ~k and that preclearing the lysates of PLC~/1-binding proteins reduces the level of tyrosine-phosphorylated p56 ~ to that of unstimulated cells. This observation, coupled with the inability of PLC3'I to bind to p56 ~k from unstimulated cells, suggests that PLC3,1 selectively binds the subset of p5C ~ that is tyrosine phosphorylated as a result of TCK stimulation. We are currently investigating whether this reflects phosphorylation of different tyrosine residues of p56 ~k and whether the PLC71-associated p56 ~ derives from the pool that is associated with CD4. Another important issue is whether interaction with a small fraction of cellular pSC k can account for PLC~/1 phosphorylation. It is interesting in this regard that the tyrosine phosphorylation of PLC3,1 after TCK stimulation appears to involve <5% of cellular PLC71, with only 1% of PLCyl associating with CD3 (12) .
In addition to p56 ~k, we observed several other tyrosinephosphorylated molecules that associate with PLC3,1 as a result of TCR stimulation. The identities of these molecules are not known. Their size distinguishes them from known components of the TCR complex. The time course for the binding of the pp36 and pp38 molecules to the PLC3'I SH2 fusion protein is very similar to that of p56 ~k. The presence of pp36, pp38, and p56 ~ in the PLC3,1 precipitates suggests two general models for the association of p56 ~k with PLC3,1. In the first model, p56 ~k binds directly to the SH2 domains of PLC3,1, and this binding is independent of pp36 and pp38. In the alternative model, the association of p56 ~i with PLC3,1 requires the participation of pp36 and pp38. For example, p56 lck might bind directly to pp36 and pp38, and the resulting complex would interact with the SH2 domains of PI.C3~1. In this model, pp36 and p38 would subserve a docking function that allows the physical approximation of p56 ~k and PLC3,1, and the tyrosine phosphorylation of pp36 and pp38 could represent a key step in TCR-mediated activation of PLC3,1. Further characterization of pp36 and pp38 should distinguish between these possibilities and shed light on the physiological functions of these molecules.
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